ArticleWorld journal of gastroenterology2025

Real-world comparison of chemotherapy plus bevacizumab with or without immunotherapy as first-line therapy in colorectal cancer.

Zhao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.